Mindful Health Solutions is one of the nation’s leading providers of innovative behavioral health care with a focus on emerging psychedelic research, precision medicine, and cutting-edge treatment protocols such as TMS, Esketamine, and IV Ketamine for patients struggling with treatment-resistant depression and other psychiatric illnesses. We founded one of the first TMS-focused clinics in the US and have deep expertise in the field of non-invasive brain stimulation. We then went on to establish one of the first clinics to provide Esketamine (Spravato) therapy at scale, and recently incorporated IV Ketamine into our depression treatment pathway.
Patients at Mindful Health Solutions have access to true thought leaders in the field focused on bringing academic rigor and years of experience with novel therapeutics to an integrated treatment strategy. We are currently leaning into the promise of psychedelic therapies for depression and PTSD as well as leveraging our extensive clinical outcomes repository to develop predictive algorithms that will help guide our clinicians in selecting the best treatment modality for their patients.
We have grown to 22 outpatient clinics located in California, Texas, and Washington and continue to expand our innovative, precision-medicine platform into new markets.
Neurotrack is a cognitive care enablement platform that helps health systems, Medicare Advantage plans, ACOs, and value-based primary care groups find and diagnose cognitive impairment earlier.
Dementia goes undiagnosed in primary care at alarming rates. Neurotrack gives care teams a practical way to change that at scale. Providers use our science-backed digital cognitive screening and assessment during routine care, including the Medicare Annual Wellness Visit (AWV), and patients can complete it in clinic or at home. Results are scored automatically and connect to a structured clinical pathway and patient-specific care plans through Smart Logic™, our proprietary clinical decision support engine. This helps primary care teams move from a positive screen to a confident dementia diagnosis and clear next steps. Neurotrack integrates with leading EHRs, including Epic and athenahealth, so results flow directly into the patient record and clinical workflow.
We also support providers with CME courses and patient education resources.
Neurotrack has published 27 peer-reviewed papers, holds 11 patents, and is registered as an FDA Class II medical device. Learn more at neurotrack.com.